Story thread · 2 reports / 2 sources
PharmAla Issues Q3 Financial Statements and AGM Update
financialpost.com · 12d
TORONTO, July 30, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial and operational results for the period ended […]
First report: PharmAla Issues Q3 Financial Statements and AGM Update — thestar.com, 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.